These pharmacologic effects correlated with SAMHD1 protein abundance and, furthermore, could overcome the SAMHD1‐mediated barrier to ara‐C efficacy in AML xenograft mouse models. This evidence concerns the gene SAMHD1 and acute myeloid leukemia.